Dimensional Fund Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.08M | Buy |
1,411,263
+227,537
| +19% | +$819K | ﹤0.01% | 2515 |
|
|
2025
Q1 | $3.54M | Buy |
1,183,726
+206,256
| +21% | +$617K | ﹤0.01% | 2597 |
|
|
2024
Q4 | $3.27M | Buy |
977,470
+183,844
| +23% | +$616K | ﹤0.01% | 2655 |
|
|
2024
Q3 | $2.66M | Buy |
793,626
+199,266
| +34% | +$668K | ﹤0.01% | 2713 |
|
|
2024
Q2 | $1.97M | Buy |
594,360
+211,428
| +55% | +$700K | ﹤0.01% | 2763 |
|
|
2024
Q1 | $1.55M | Buy |
382,932
+290,581
| +315% | +$1.17M | ﹤0.01% | 2841 |
|
|
2023
Q4 | $282K | Hold |
92,351
| – | – | ﹤0.01% | 3144 |
|
|
2023
Q3 | $277K | Hold |
92,351
| – | – | ﹤0.01% | 3154 |
|
|
2023
Q2 | $345K | Buy |
92,351
+30,712
| +50% | +$115K | ﹤0.01% | 3136 |
|
|
2023
Q1 | $206K | Buy |
+61,639
| New | +$206K | ﹤0.01% | 3193 |
|
|
2021
Q2 | – | Sell |
-3,683
| Closed | -$227K | – | 3461 |
|
|
2021
Q1 | $227K | Buy |
+3,683
| New | +$227K | ﹤0.01% | 3271 |
|